/Investor DB

AbbVie — 2018 Investments

3 investments dated 2018 · listed companies and verified rows first · show all

Carawaycarawaytx.comin𝕏Series A · Nov 2018 · $23Macquired by Merck

Caraway Therapeutics was a preclinical biopharmaceutical company developing small-molecule therapies modulating lysosomal function to treat neurodegenerative and rare diseases.

BiotechHealthtech

Co-investorsDementia Discovery FundEisai Innovation, Inc.McCarthy CapitalMRL Ventures FundSpringdale VenturesSV Health Investors+9 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Magnolia NeurosciencesParagen Bio

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.